Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium

Occupational and Environmental Medicine

Volumn 55, Issue 7, 1998, Pages 446-452

  Chalkley, S R ^a   Richmond, J ^a   Barltrop, D ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Blood; Cadmium; Lead; Smelter workers; Total proteins; Urine; Vitamin D3 metabolites

Indexed keywords

CADMIUM; COLECALCIFEROL; LEAD; 24,25 DIHYDROXYCOLECALCIFEROL; CALCIFEDIOL; CALCITRIOL;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; ENVIRONMENTAL EXPOSURE; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; OCCUPATIONAL HAZARD; OSTEOMALACIA; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; SMELTER; URINALYSIS; ANALYSIS OF VARIANCE; BLOOD; MALE; METABOLISM; METALLURGY; OCCUPATIONAL EXPOSURE; PROTEINURIA; URINE;

24,25-DIHYDROXYVITAMIN D 3; ANALYSIS OF VARIANCE; CADMIUM; CALCIFEDIOL; CALCITRIOL; CHOLECALCIFEROL; HUMANS; LEAD; MALE; METALLURGY; OCCUPATIONAL EXPOSURE; PROTEINURIA;

EID: 0031596178     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.55.7.446     Document Type: Article

References (54)

1. Lockitch G. Perspectives on lead toxicity [review]. Clin Biochem 1993;26:371-81.
2. Tandon SK, Khandelwal S, Jain VK, et al. Influence of dietary iron deficiency on acute metal intoxication. Biometals 1993;6:133-8
3. Barry PS, Mossman DB. Lead concentrations in human tissues. Br J Ind Med 1970;27:339-51.
4. Hicks DG, O'Keefe RJ, Reynolds KJ, et al. Effects of lead on growth-plate chondrocyte phenotype. Toxicol Appl Pharmacol 1996;140:164-72.
5. Borjesson J, Mattsson S, Stromberg U, et al. Lead in fingerbone: a tool for retrospective exposure assessment. Arch Environ Health 1997;52:104-12.
6. Kjellstrom T. Mechanism and epidemiology of bone effects of cadmium. IARC Sci Publ 1992;118:301-310.
7. Roels H, Bernard AM, Cardenas A, et al. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med 1993;50:37-48.
8. Hido T, Honda R, Yamada Y, et al. α1-Microglobulin determination in urine for the early detection of renal tubular dysfunctions caused by exposure to cadmium. Toxicol Lett 1985;24:195-201.
9. Steenbock H, Black A. Vitamin D. J Biol Chem 1924;61:405.
10. Hess AF, Weinstock M. Vitamin D. J Biol Chem 1924;62: 301
11. Holick MF. The cutaneous photosynthesis of pre-vitamin D3: a unique photo-endocrine system. J Invest Dermatol 1981;77:51-8.
12. Windaus A, Schenk F, von Werder F. Isolation of Vitamin D. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 1936;241: 100-1.
13. Takeuchi A, Okano T, Kobayashi T. The existence of 25-hydroxyvitamin D3-1 alpha-hydroxylase in the liver of carp and bastard halibut. Life Sciences 1991;48: 275-82.
14. Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Mature 1970;228: 764-6.
15. Burgos-Trinidad M, DeLuca HF. Kinetic properties of 25-hydroxyvitamin D-and 1,25-dihydroxyvitamin D-24-hydroxylase from chick kidney. Biochem Biophys Acta 1991; 1078:226-30.
16. Gray RW, Ghazarian JG. Solubilization and reconstitution of kidney 25-hydroxyvitamin D3 1α-and 24-hydroxylases from vitamin D replete pigs. Biochem J 1989;259:561-8.
17. Mandel ML, Moorthy B, Swam SJ, et al. Monoclonal antibodies to chick renal calcium regulating hemeproteins. Biochemical and immunohistochemical interactions with mitochondrial 25-hydroxyvitamin D3 hydroxylases. J Clin Lab Immunol 1990;31:1-10.
18. Rubin LP, Yeung B, Vouros P, et al. Evidence for human placental synthesis of 24,25-dihydroxyvitamin D3 and 23,25-dihydroxyvitamm D3. Ped Res 1993;34:98-104.
19. Bikle DD, Halloran BP, Riviere JE. Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol 1994;102:796-8.
20. Guilhou JJ, Colette C, Monpoint S, et al. Vitamin D metabolism in psoriasis before and after phototherapy. Acta Derm Venereol 1990;70:351-4.
21. Wasserman RH, Brindak ME, Buddle MM, et al. Recent studies on the biological actions of vitamin D on intestinal transport and the electrophysiology of peripheral nerve and cardiac muscle [review]. Prog Clin Biol Res 1990;332:99-126.
22. Fuss M, Pepersack T, Gillet C, et al. Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 1992;11:28-36.
23. Miyaura C, Suda T. Vitamin D [review]. Jap J Clin Med 1993;51:893-900. [Japanese]
24. Rubinger D, Krause I, Alkoby-Gibbs M, et al. 24,25(OH)2D3 affects the calcemic effects of 1,25(OH)2D3 by mechanisms independent of intestinal calcium absorption. Bone and Mineral 1991;15:219-26.
25. Matsumoto T, Yamato H, Okazaki R, et al. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Proc Soc Exp Biol Med 1992;200:161-4.
26. Yamato H, Okazaki R, Ishii T, et al. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int 1993;52:255-60.
27. Grosse B, Bourdeau A, Lieberherr M. Oscillations in inositol 1,4,5-trisphosphate and diacyglycerol induced by vitamin D3 metabolites in confluent mouse osteoblasts. J Bone Miner Res 1993;8:1059-69.
28. Fullmer CS, Rosen JF. Effect of dietary calcium and lead status on intestinal calcium absorption. Environ Res 1990;51:91-9.
29. Long GJ, Rosen JF, Pounds JG. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells. Toxicol Appl Pharmacol 1990;106:270-7.
30. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone, [review]. Environ Health Perspect 1991; 91:17-32.
31. Fullmer CS, Edelstein S, Wasserman RH. Lead-binding properties of intestinal calcium-binding proteins. J Biol Chem 1985;260:6816-9.
32. Rosen JF, Chesney RW, Hamstra A, et al. Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med 1980;302:1128-31.
33. Yoshiki S, Yanagisawa T, Kimura M, et al. Bone and kidney lesions in experimental cadmium intoxication. Arch Environ Health 1975;30:559-62.
34. Kazantzis G, Armstrong BG. Renal function in relation to low levels of cadmium exposure in a group of smelter workers. Environ Health Perspect 1984;54:193-9.
35. Kazantzis G, Lam TH, Sullivan KR. Mortality of cadmium-exposed workers. A five-year update. Scand J Work Environ Health 1988;14:220-3.
36. Lidor C, Sagiv P, Amdur B, et al. Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int 1993;52: 146-8.
37. Edelstein S, Charman M, Lawson DE, et al. Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med 1974;46:231-40.
38. Macart M, Gerbaut L. An improvement of the Coomassie blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid. Clin Chim Acta 1982;122:93
39. Macart M, Gerbaut L. Evaluation of an improved Coomassie blue dye binding method for urinary protein assay. Clin Chim Acta 1984;141:77
40. Rosen JF, Chesney RW. Medical progress: circulating calcitriol concentrations in health and disease. J Pediatr 1983;103:1-17.
41. Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the US population. Phase I of the third National Health and Nutrition Examination Study (NHANES III 1988 to 1991). JAMA 1994;272:277-83.
42. Staessen J, Lauwerys R. Health effects of environmental exposure to cadmium in a population study. J Hum Hypertens 1993;7:195-9.
43. Mahaffey KR, Rosen JF, Chesney RW, et al. Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr 1982;35:1327-31.
44. Ghazarian JG. The renal mitochondrial hydroxylases of the vitamin D3 endocrine complex: how are they regulated at the molecular level? [review]. J Bone Miner Res 1990;5: 897-903.
45. Long GJ, Pounds JG, Rosen JF. Lead intoxication alters basal and parathyroid hormone-regulated cellular calcium homeostasis in rat osteosarcoma (ROS 17/2.8) cells. Calcif Tissue Int 1992;50:451-8.
46. Katsuta O, Hiratsuka H, Matsumoto J, et al. Cadmium-induced osteomalacic and osteopetrotic lesions in ovariectomized rats. Toxicol Appl Pharmacol 1994;126:58-68.
47. Gur E, Waner T, Barushka Eizik O, et al. Effect of cadmium on bone repair in young rats. J Toxicol Environ Health 1995; 45:249-60.
48. Nolan CV, Shaikh ZA. Lead nephrotoxicity and associated disorders: biochemical mechanisms, [review]. Toxicology 1992;73:127-46.
49. Walton JR. Intracellular inclusions in the lead-poisoned cultured kidney cell. J Pathol 1974;112:213.
50. Goyer RA. Transplacental transport of lead, [review]. Environ Health Perspect 1990;89:101-5.
51. Ehle AL, McKee DC. Neuropsychological effect of lead in occupationally exposed workers: a critical review. Crit Rev Toxicol 1990;20:237-55.
52. Saha HH. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994;41:290-6.
53. Navarro JA, Granadillo VA, Salgado O, et al. Bone metal content in patients with chronic renal failure. Clin Chim Acta 1992;211:133-42.
54. Nogawa K, Tsuritani I, Kido T, et al. Serum vitamin D metabolites in cadmium-exposed persons with renal damage. Int Arch Occup Environ Health 1990;62:189-93.